Filing Details

Accession Number:
0000950117-11-000368
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-14 17:14:07
Reporting Period:
2011-04-12
Filing Date:
2011-04-14
Accepted Time:
2011-04-14 17:14:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420720 Ibio Inc. IBIO Pharmaceutical Preparations (2834) 262797813
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1102948 Carl Desantis 3299 Nw 2Nd Avenue
Boca Raton FL 33431
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-12 250,000 $0.50 5,164,541 No 4 S Indirect FN
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect FN
Footnotes
  1. Shares sold in a private transaction pursuant to a Stock Option Agreement originally entered into on May 21, 2010 with Kobus Investments, LLC and Biomed Investments, LLC, as described in detail in the Issuer's Registration Statement on Form S-3 filed with the SEC on March 14, 2011.
  2. Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc., of which the reporting person is a controlling person, (iii) 1,406,293 shares of common stock held by CD Financial, LLC, (iv) 250,000 shares of common stock issuable upon exercise of a warrant held by CD Financial, LLC, and (v) 2,235,417 shares of common stock held by the DeSantis Revocable Trust.